What's new in Interventional Cardiology

At PCR, collaboration and inclusion are at the heart of everything we do.

Together, we create an environment where expertise is shared, talents complement each other, and diversity becomes a strength. It is this collective spirit that drives interventional cardiology forward and inspires innovation every day.

During PCR London...

This individual patient data analysis of the three largest RCTs evaluating IVUS-guided stent optimisation showed that an MSA > 5.5 mm2 was associated with reduced TVF at one year. 

View a snapshot of the results of these 4 trials in valvular and structural interventions presented in London during this year's Heart Team Course!

At 7 years, low-risk patients affected by severe symptomatic aortic valve stenosis 1:1 randomly treated by SAPIEN 3 TAVI or surgery showed similar clinical outcomes and late valve durability

Alessandro Sticchi provides us with a curated overview of the late-breaking trials he found most relevant for interventional cardiologists from AHA 2025.

Edoardo Zancanaro interviews Julien Dreyfus & David Messika-Zeitoun about the MITRACURE registry, a large international initiative aimed at capturing real-world data on patients with mitral regurgitation referred for surgery. in 2019. The study shows outcomes differ from expert centers, with higher mortality and lower repair rates, especially...

Advancing a transcatheter heart valve through the septostomy can be tricky, with the wire sometimes prolapsing into the left atrium.

This step-by-step tutorial demonstrates a simple yet effective maneuver that allows smooth, controlled navigation from the right atrium to the mitral position, ensuring precise valve deployment.

Kalaivani Mahadevan and Sofia Papadopoulou provide their take on the INVEST CTO trial, presented by Anja Oksnes at TCT 2025, in San Francisco.

Kalaivani Mahadevan and Trisha Singh provide their take on the PROCTOR study presented by Ruben de Winter at TCT 2025, in San Francisco.

Alex Sticchi provides his take on the iCABG trial presented by Rasa Ordiene at TCT 2025, in San Francisco.